Juan Hao
Hongkou, 200086, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Asparaginase enhances CAR-T cell antitumor immunity by asparagine metabolic reprogramming and central memory induction in ALL.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 23, 2025
BCKDK modification enhances the anticancer efficacy of CAR-T cells by reprogramming branched chain amino acid metabolism.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 15, 2023
Gentiopicroside Ameliorated Ductular Reaction and Inflammatory Response in DDC-induced Murine Cholangiopathies Model
Journal: Current molecular pharmacology
Published: March 28, 2023
Oncometabolite D-2-hydroxyglutarate-dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia.
Journal: Communications biology
Published: March 27, 2023
Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease.
Journal: Journal of traditional and complementary medicine
Published: September 15, 2022
D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 06, 2021
Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia.
Journal: Journal of cachexia, sarcopenia and muscle
Published: March 28, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026